Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from GSK

GSK's Blood Cancer Drug Review Extended As FDA Seeks More Data

The US Food and Drug Administration (FDA) on Wednesday extended the review period for the Biologics License Application (BLA) for GSK plc’s (NYSE:GSK) Blenrep combinations for relapsed or refractory multiple myeloma patients who have received at least one prior line of therapy.

Benzinga

GSK's Blood Cancer Drug Faces US Setback Due To FDA Panel's Eye Safety Warning

The U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of GSK plc’s (NYSE:GSK) Blenrep (belantamab mafodotin-blmf) combinations.

Benzinga

GSK Seeks FDA Nod To Broaden RSV Vaccine For Younger At-Risk Adults

On Monday, the U.S. Food and Drug Administration (FDA) agreed to review GSK plc’s (NYSE:GSK) application to extend the indication of Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted) to adults aged 18-49 who are at increased risk.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Pfizer, Sanofi Find Relief As Delaware Top Court Rejects Zantac Expert Testimony

The Delaware Supreme Court has overturned a lower court’s decision that allowed expert testimony supporting plaintiffs’ claims in a high-profile case alleging that Zantac, or its generic ranitidine, can cause cancer.

Benzinga

Weak retail sales and falls in key oil and drug stocks stifle FTSE 100

The FTSE 100 index closed down 17.15 points, 0.2%, at 8,774.65.

Evening Standard

From AI to aerospace: Europe's most innovative companies shaping tomorrow

For the first time, Fortune analyzed the top companies across the continent in partnership with Statista to find the standouts that are driving progress with success.

Fortune

Queens of influence: Meet the women shaping Europe's future

In its 28th year, the annual MPW list recognizes 100 women leading major global companies. This year, 21 listees are at the helm of European companies.

Fortune

Read news from The Economist, FT, and more,
with one subscription

The UK is rolling out a world-first vaccine for gonorrhoea. What about the rest of Europe?

The UK will offer a vaccine originally intended to prevent meningitis, which is caused by a bacteria with a similar genetic profile to the one that causes gonorrhoea.

Euronews

British boss of US healthcare giant UnitedHealth quits for ‘personal reasons’

The move comes five months after one of the company’s top executives was killed after being shot as he walked to an investor conference in New York.

Evening Standard

Tariff turmoil prompts cloudy forecasts from companies for the year ahead

Uncertainty continues to hang over the latest round of financial results and forecasts for companies both big and small as they try to navigate a global trade system severely shaken by a stark shift in U.S. policy

The Independent UK

Wall Street falls while FTSE 100 regains losses after US economy shrinks

The American economy contracted by 0.3% in the first three months of the year amid Donald Trump’s threats of sweeping trade tariffs.

Evening Standard

Drugs giant GSK ‘well positioned’ to absorb potential US tariffs

It came as the FTSE 100 giant revealed a rise in sales as weakness in its vaccine division was offset by growth in speciality medicines.

Evening Standard

The impact Trump’s tariffs could have on the NHS

IN FULL

The Independent UK

Pharmaceuticals are the next Trump tariff battleground - what will they mean for the NHS?

TRUMP TARIFFS: UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

EU drug companies warn of exodus to US as Trump threatens import tariffs

Von der Leyen urged to take ‘rapid and radical action’ as president says tariffs on pharmaceuticals coming ‘shortly’

Evening Standard

Trump tariffs: Which UK sectors will be hit hardest?

The PA news agency looks at which sectors will be most affected by the plans and what it means for businesses and households.

Euronews

Shingles vaccine tied to a 20% lower risk of dementia among older people

The findings add to a growing body of evidence that the shingles vaccine may help keep dementia at bay – but researchers still need to prove it.

Fortune

GSK employees perform anonymous ‘180’ surveys on their bosses, and CEO Emma Walmsley isn’t exempt

Emma Walmsley says her "180" would probably tell her to say "thank yous" and "well dones."

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

FDA approves new UTI antibiotic that may help patients with recurring infections

A commercial launch of the antibiotic in the U.S. is planned during the second half of 2025

Medical Daily

New Antibiotics For UTI Gets FDA Approval- First In 30 Years

The FDA has approved a new antibiotic, Gepotidacin (Blujepa), for treating uncomplicated urinary tract infections (UTIs) in women and girls aged 12 and older.

Fortune

From $6 billion unicorn to bankrupt cautionary tale: The story of 23andMe

DNA testing company 23andMe was a white-hot Silicon Valley startup for years, and Anne Wojcicki was a celebrity CEO. But after going public, investors lost faith in the DNA testing company.

Evening Standard

Pfizer offloads final shares in Sensodyne maker Haleon

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US rival Pfizer.

The Independent UK

Doctors didn’t warn ‘deviant sexual behaviour’ was side effect of restless legs syndrome drug

Patients claim GPs did not tell them about significant potential side effects of treatment

Fortune

Power Players: Meet the women reshaping 10 key European industries

This year, Fortune curated a list of female leaders at the helm of European companies across the continent’s biggest industries.

Fortune

23andMe was once worth $6 billion. Now CEO Anne Wojcicki wants to buy it back for $42 million

Experts say the CEO’s second attempt to buy back the troubled DNA startup comes with a slew of corporate governance red flags.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.